|
Therapy for Nerve Agent Poisoning
|
journal
|
May 2004 |
|
Mouse and Rat Anesthesia and Analgesia
|
journal
|
January 2008 |
|
Timing is everything: Where status epilepticus treatment fails
|
journal
|
July 2017 |
|
Neurosteroid and benzodiazepine combination therapy reduces status epilepticus and long‐term effects of whole‐body sarin exposure in rats
|
journal
|
June 2019 |
|
Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman‐induced epileptogenesis and brain pathology in rats
|
journal
|
October 2021 |
|
Anticonvulsants for soman-induced seizure activity
|
journal
|
March 1999 |
|
Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug
|
journal
|
May 1995 |
|
Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats
|
journal
|
April 2018 |
|
Memantine and Its Combination with Acetylcholinesterase Inhibitors in Pharmacological Pretreatment of Soman Poisoning in Mice
|
journal
|
July 2021 |
|
Effects of non-opioid antitussives on epileptiform activity and NMDA responses in hippocampal and olfactory cortex slices
|
journal
|
October 1990 |
|
Effects of memantine on the twitch tension of mouse diaphragm
|
journal
|
January 1989 |
|
Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons
|
journal
|
March 1992 |
|
Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat
|
journal
|
January 1992 |
|
Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rat*1
|
journal
|
April 1991 |
|
Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents
|
journal
|
March 1991 |
|
A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning
|
journal
|
February 1991 |
|
NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures
|
journal
|
March 1990 |
|
Self-sustaining status epilepticus after brief electrical stimulation of the perforant path
|
journal
|
August 1998 |
|
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
|
journal
|
February 2003 |
|
Control of nerve agent-induced seizures is critical for neuroprotection and survival☆ ☆The animals used in these studies were handled in accordance with the principles stated in the Guide for the Care and Use of Laboratory Animals, proposed by the Committee to Revise the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council, and published by National Academy Press, 1996, and the Animal Welfare Act of 1966, as amended. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as reflecting the views of the Department of the Army or the Department of Defense.
|
journal
|
April 2003 |
|
Organophosphorus Nerve Agents-Induced Seizures and Efficacy of Atropine Sulfate as Anticonvulsant Treatment
|
journal
|
September 1999 |
|
Novichok nerve agent poisoning
|
journal
|
January 2021 |
|
Pharmacological modulation of soman-induced seizures
|
journal
|
June 1993 |
|
Neuropharmacological Mechanisms of Nerve Agent-induced Seizure and Neuropathology 1 1The animals used in studies performed in, or sponsored by, this Institute were handled in accordance with the principles stated in the Guide for the Care and Use of Laboratory Animals, proposed by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council, DHHA, National Institute of Health Publication #85–23, 1985, and the Animal Welfare Act of 1966, as amended. The opinions, or assertions contained herein are the private views of the authors, and are not to be construed as reflecting the views of the Department of the Army or the Department of Defense.
|
journal
|
January 1997 |
|
Delta Activity as an Early Indicator for Soman-Induced Brain Damage: A Review
|
journal
|
June 2001 |
|
Caramiphen and Scopolamine Prevent Soman-Induced Brain Damage and Cognitive Dysfunction
|
journal
|
May 2002 |
|
N-methyl-d-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat
|
journal
|
April 1999 |
|
N-Methyl-d-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam
|
journal
|
June 1999 |
|
Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs
|
journal
|
December 1999 |
|
A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat
|
journal
|
February 2000 |
|
Medical management of organophosphate-induced seizures
|
journal
|
October 1998 |
|
Status epilepticus: pathophysiology and management in adults
|
journal
|
March 2006 |
|
Mechanisms of ketamine and its metabolites as antidepressants
|
journal
|
March 2022 |
|
Organophosphorus nerve agent poisoning: managing the poisoned patient
|
journal
|
October 2019 |
|
Efficacy of the ketamine–atropine combination in the delayed treatment of soman-induced status epilepticus
|
journal
|
July 2005 |
|
Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats
|
journal
|
September 2012 |
|
Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives
|
journal
|
March 2013 |
|
Oximes in organophosphate poisoning: 60 years of hope and despair
|
journal
|
November 2016 |
|
Dataset of EEG power integral, spontaneous recurrent seizure and behavioral responses following combination drug therapy in soman-exposed rats
|
journal
|
December 2019 |
|
Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR
|
journal
|
December 2019 |
|
Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning
|
journal
|
December 2006 |
|
The control of kainic acid-induced status epilepticus
|
journal
|
June 2010 |
|
Environmental exposure to organophosphorus nerve agents
|
journal
|
December 2017 |
|
Sarin experiences in Japan: Acute toxicity and long-term effects
|
journal
|
November 2006 |
|
Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus
|
journal
|
June 2013 |
|
Simultaneous triple therapy for the treatment of status epilepticus
|
journal
|
August 2017 |
|
Rational polytherapy in the treatment of cholinergic seizures
|
journal
|
January 2020 |
|
Diet composition modifies the toxicity of repeated soman exposure in rats
|
journal
|
December 2011 |
|
Pathophysiological mechanisms underlying increased anxiety after soman exposure: Reduced GABAergic inhibition in the basolateral amygdala
|
journal
|
September 2014 |
|
Beneficial effects of a ketamine/atropine combination in soman-poisoned rats under a neutral thermal environment
|
journal
|
September 2015 |
|
Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes
|
journal
|
December 2018 |
|
Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-d-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors
|
journal
|
April 2009 |
|
The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: Relation to anxiety-like behavior
|
journal
|
June 2014 |
|
LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety
|
journal
|
February 2015 |
|
Mechanisms of action of currently used antiseizure drugs
|
journal
|
May 2020 |
|
Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures
|
journal
|
December 2020 |
|
Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors
|
journal
|
March 2021 |
|
Effects of Diazepam and Ketamine on Pilocarpine-Induced Status Epilepticus in Mice
|
journal
|
November 2019 |
|
Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats
|
journal
|
July 2014 |
|
Impaired auditory and contextual fear conditioning in soman-exposed rats
|
journal
|
March 2011 |
|
Pathophysiology of convulsive status epilepticus
|
journal
|
May 2019 |
|
Efficacy of antidotal treatment against sarin poisoning: The superiority of benactyzine and caramiphen
|
journal
|
February 2008 |
|
Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice
|
journal
|
March 2012 |
|
The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: Synergism with the benzodiazepine diazepam
|
journal
|
March 2012 |
|
Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat
|
journal
|
May 2021 |
|
Protective effects of S(+) ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs
|
journal
|
May 2007 |
|
Prophylactic potential of memantine against soman poisoning in rats
|
journal
|
March 2019 |
|
Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital
|
journal
|
May 2019 |
|
Early polytherapy for benzodiazepine-refractory status epilepticus
|
journal
|
December 2019 |
|
Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice
|
journal
|
October 2020 |
|
Muscarinic receptor binding profile of para-substituted caramiphen analogs
|
journal
|
October 1991 |
|
Production of ES1 Plasma Carboxylesterase Knockout Mice for Toxicity Studies
|
journal
|
November 2011 |
|
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
|
journal
|
May 2016 |
|
Edging toward breakthroughs in epilepsy diagnostics and care
|
journal
|
October 2015 |
|
The anticonvulsant actions of σ receptor ligands in the Mg2+ -free model of epileptiform activity in rat hippocampal slices
|
journal
|
July 1998 |
|
Mechanism of action of benzodiazepines on GABAAreceptors
|
journal
|
August 2006 |
|
Short-Term Plasticity of Hippocampal Neuropeptides and Neuronal Circuitry in Experimental Status Epilepticus
|
journal
|
July 2002 |
|
Long-lasting reduction of inhibitory function and gamma-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy.
|
journal
|
September 1996 |
|
Prevention and antagonism of acute carbofuran intoxication by memantine and atropine
|
journal
|
September 1989 |
|
Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats
|
journal
|
June 2016 |
|
How many premature deaths from pesticide suicide have occurred since the agricultural Green Revolution?
|
journal
|
September 2019 |
|
Review of Oximes in the Antidotal Treatment of Poisoning by Organophosphorus Nerve Agents
|
journal
|
January 2002 |
|
Age-Related Susceptibility to Epileptogenesis and Neuronal Loss in Male Fischer Rats Exposed to Soman and Treated With Medical Countermeasures
|
journal
|
March 2018 |
|
Inhibition by Ketamine of Muscarinic Acetylcholine Receptor Function
|
journal
|
July 1995 |
|
Stereospecific Interaction of Ketamine with Nicotinic Acetylcholine Receptors in Human Sympathetic Ganglion-like SH-SY5Y Cells
|
journal
|
September 2000 |
|
Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits
|
journal
|
August 2016 |
|
Treatment of experimental status epilepticus with synergistic drug combinations
|
journal
|
February 2017 |
|
Soman‐induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam
|
journal
|
October 2018 |
|
Blockade by sigma site ligands of N-methyl-D-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurones
|
journal
|
December 1995 |
|
Blockade by sigma site ligands of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones
|
journal
|
December 1995 |
|
Neuroprotective efficacy of caramiphen against soman and mechanisms of its action
|
journal
|
October 2011 |
|
Cognitive Functions After Pilocarpine-Induced Status Epilepticus: Changes During Silent Period Precede Appearance of Spontaneous Recurrent Seizures
|
journal
|
September 1999 |
|
Self-Sustaining Status Epilepticus: A Condition Maintained by Potentiation of Glutamate Receptors and by Plastic Changes in Substance P and Other Peptide Neuromodulators
|
journal
|
June 2000 |
|
GABA Synapses and the Rapid Loss of Inhibition to Dentate Gyrus Granule Cells after Brief Perforant-Path Stimulation
|
journal
|
July 2005 |
|
A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation
|
journal
|
February 2008 |
|
Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats
|
journal
|
January 2010 |
|
Long-term neuropathological and behavioral impairments after exposure to nerve agents
|
journal
|
March 2016 |
|
Delayed midazolam dose effects against soman in male and female plasma carboxylesterase knockout mice
|
journal
|
February 2020 |
|
Sex as a biological variable in the rat model of diisopropylfluorophosphate‐induced long‐term neurotoxicity
|
journal
|
February 2020 |
|
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
|
journal
|
June 2018 |
|
U.K. attack puts nerve agent in the spotlight
|
journal
|
March 2018 |
|
Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition
|
journal
|
February 1989 |
|
Transcriptional responses of the nerve agent-sensitive brain regions amygdala, hippocampus, piriform cortex, septum, and thalamus following exposure to the organophosphonate anticholinesterase sarin
|
journal
|
July 2011 |
|
Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure
|
journal
|
July 2006 |
|
Treatment of Experimental Status Epilepticus in Immature Rats: Dissociation Between Anticonvulsant and Antiepileptogenic Effects
|
journal
|
February 2006 |
|
Therapy for acute nerve agent poisoning
|
journal
|
April 2019 |
|
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
|
journal
|
July 2017 |
|
The Anticonvulsant Response to Valproate in Kindled Rats Is Correlated with Its Effect on Neuronal Firing in the Substantia Nigra Pars Reticulata: A New Mechanism of Pharmacoresistance
|
journal
|
November 2011 |
|
Subunit-Specific Trafficking of GABAAReceptors during Status Epilepticus
|
journal
|
March 2008 |
|
Trafficking of GABAAReceptors, Loss of Inhibition, and a Mechanism for Pharmacoresistance in Status Epilepticus
|
journal
|
August 2005 |
|
Ketamine, But Not Phencyclidine, Selectively Modulates Cerebellar GABAAReceptors Containing α6 and δ Subunits
|
journal
|
May 2008 |
|
Follow-up of Sarin Poisoning in Matsumoto
|
journal
|
December 1997 |
|
Lessons Learned From the Syrian Sarin Attack: Evaluation of a Clinical Syndrome Through Social Media
|
journal
|
May 2014 |